Sat, Aug 30, 2014, 6:31 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Immune Response Corp. (IMNR) Message Board

  • ShaharAvi ShaharAvi Jun 23, 1998 1:56 PM Flag

    A Few Thoughts

    First, I have really enjoyed the give & take
    between posters on the merits of Remune (you know who you
    are), and am impressed by the civility of the
    debate.

    Second, FWIW, I'd like to make an early plea to everyone
    to not turn this thread into a 1-800 Chat Line
    during the Geneva conference and concomitant
    hypothesized price/volume volatility. It's hard enough getting
    through this board as is, but experience shows that price
    volatility brings out a lot of loose energy on various
    boards. So, an early plea to limit postings to
    substantive issues.

    Third, IMHO, I am a bigger fan of
    IMNR's cancer products than the GeneDrugs. I like what I
    read about their approach and the cancer products are
    certainly further along the pipeline. Nobody is talking
    about the cancer products. Too, psoriasis is a
    tremendously large market and if the Ph2 results - to be
    released any week now - are positive there will be
    significant price appreciation. Nobody is talking about this
    event either. I agree with others that Remune will
    make/break IMNR for the very short term, but these other
    products add SIGNIFICANT value.

    Finally, I would
    not encourage anyone to daytrade IMNR. I believe
    there are 2 saner ways to time your "sells" if you're
    long IMNR and think it may be going up. One way is to
    simply have your own price target in mind and sell
    if/when the stock hits that point. A better way perhaps
    is to incorporate stop/loss orders as well. (Now,
    I'm well aware of the potential pitfalls of using
    such orders, but I don't feel that these will apply to
    IMNR so I'm not going to mention them.) A stop/loss
    order is simply a sell order where you've specified the
    selling price which will be below the stock's current
    price. If the stock was at 20 and you wanted to lock in
    profits, you might set your order at 18. If the stock
    drops 2 points (yes, or more), your order gets filled.
    If the stock con't higher, simply keep moving your
    stop/loss order target price higher. Decide what cushion
    you want below current price (i.e., # of points or a
    certain %). These orders can allow one to benefit from
    "market excess" or "momentum" - i.e., in situations when
    the stock hit your independent target price but keeps
    going higher. With stop/loss, instead of selling at
    your original target price, you can participate/profit
    by the "excess" rise in the stock.

    P.S. to
    Inflamm: If I was having as good a '98 with biotech as
    I've been with my OTB horserace stakes betting, IPIC
    would be at 30! Unfortunately for me, my biotech bets
    dwarf my horse bets.

    The reason for this last
    primer is my conviction that no amateur can compete well
    with "the Street" when it comes to day trading or
    stock timing. We can all get lucky, in the long run we
    aren't going to win. The Mirage in Vegas and your basic
    Brokerage House get "built" by the same mechansim - house
    odds guarantee profit.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Scorman et. all:

      This stock has just
      landed on many fund managers desk as being "worthy" of
      their $$$ based on internal criteria such as: a)
      Corporate collaboration aka a big pharma partner b) trading
      volume ...now averaging more than 500k c) upward price
      trend
      d) promising pipeline and trial
      results.

      Again, all of the posters are being too hasty to say the
      stock didn't move up on the AGPH news....it's STILL
      moving up on that news. Any further news i.e. Geneva and
      or further corporate partners and well as a Gruntal
      broker told me ..."IMNR is better than sex".

      good
      luck,

      bob

    • Shahar, I appreciate your knowledge of biotechs,
      but I would never put a stop loss on a stock like
      this. If bad news comes out chances are the price will
      gap right past the stop loss and the stock will not
      get sold. As you said the brokerages are very good at
      this game and one of their tactics is temporarily
      driving down the stock price and buying the shares that
      hit the stop loss (legalized stealing). I would
      suggest that anyone who believes in IMNR and their future
      just hold onto their shares. If the stock tanks from
      bad news, the little guy is going to be too late to
      do anything about it. Just my opinion based on many
      years in the market. Just hate to see anyone have their
      shares stolen from them.

      • 1 Reply to dreamvisions
      • I too do not believe in stop loss orders and have
        never used one in 30 years of trading/investing. BTW, a
        "stop limit" order is saner if you really want to get
        out, since it gets converted to a market order when
        the price is reached.

        My reasons are of
        psychological in nature....a stop loss is negative thinking...I
        will sell at a new high, as at 16 today (but I am not)
        and be elated but realize that a stock may go to
        20...fine....to have it go to 16 and sell at 14 is unacceptable!
        Old Joe Kennedy is quoted as saying "never look
        back". Yes, if the MM see these orders on the books,
        they will sink the stock, clear the stops, then let
        the stock rise again and yes it is robbery.


        No, there is nothing wrong with "trading" this
        stock...we are here to make money....in my opinion there is
        no such thing as a "long" position, just that we
        have to wait tooooo "long" to get what we consider
        good value for our stock.

        Stew Corman from
        sunny Endicott

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.